Differences
This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision | ||
publications [2024/04/13 17:29] ramirez [2024] |
publications [2024/04/19 17:20] anacosta [2023] |
||
---|---|---|---|
Line 2: | Line 2: | ||
===== 2024 ===== | ===== 2024 ===== | ||
+ | Faria NA, Touret T, Simões AS, Palos C, Bispo S, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M]], Carriço J, Pinto M, Toscano C, Gonçalves E, Gonçalves ML, Costa A, Araújo M, Duarte A, de Lencastre H, Serrano M, Sá-Leão R, Miragaia M. 2024. <fc #0000FF>Genomic Insights into the expansion of carbapenem-resistant //Klebsiella pneumoniae// within Portuguese Hospitals</fc>. J Hosp Infect S0195-6701(24)00106–3. [[https://www.ncbi.nlm.nih.gov/pubmed/38554808/|(PMID: 38554808)]] | ||
Xie O, Morris JM, Hayes AJ, Towers RJ, Jespersen MG, Lees JA, Ben Zakour NL, Berking O, Baines SL, Carter GP, Tonkin-Hill G, Schrieber L, McIntyre L, Lacey JA, James TB, Sriprakash KS, Beatson SA, Hasegawa T, Giffard P, Steer AC, Batzloff MR, Beall BW, [[people:mdpinho|Pinho MD]], [[people:ramirez|Ramirez M]], Bessen DE, Dougan G, Bentley SD, Walker MJ, Currie BJ, Tong SYC, McMillan DJ, Davies MR. 2024. <fc #0000FF>Inter-species gene flow drives ongoing evolution of Streptococcus pyogenes and //Streptococcus dysgalactiae// subsp. //equisimilis//</fc>. Nat Commun 15:2286. [[https://www.ncbi.nlm.nih.gov/pubmed/38480728/|(PMID: 38480728)]] | Xie O, Morris JM, Hayes AJ, Towers RJ, Jespersen MG, Lees JA, Ben Zakour NL, Berking O, Baines SL, Carter GP, Tonkin-Hill G, Schrieber L, McIntyre L, Lacey JA, James TB, Sriprakash KS, Beatson SA, Hasegawa T, Giffard P, Steer AC, Batzloff MR, Beall BW, [[people:mdpinho|Pinho MD]], [[people:ramirez|Ramirez M]], Bessen DE, Dougan G, Bentley SD, Walker MJ, Currie BJ, Tong SYC, McMillan DJ, Davies MR. 2024. <fc #0000FF>Inter-species gene flow drives ongoing evolution of Streptococcus pyogenes and //Streptococcus dysgalactiae// subsp. //equisimilis//</fc>. Nat Commun 15:2286. [[https://www.ncbi.nlm.nih.gov/pubmed/38480728/|(PMID: 38480728)]] | ||
Line 21: | Line 21: | ||
Gouveia C, Bajanca-Lavado MP, Mamede R, Araújo Carvalho A, Rodrigues F, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M.]], [[people:afriaes|Friães A]], Portuguese Group for the Study of Streptococcal Infections, Portuguese Study Group of Pediatric Invasive Streptococcal Disease. 2023. <fc #0000FF>Sustained increase of paediatric invasive //Streptococcus pyogenes// infections dominated by M1<sub>UK</sub> and diverse //emm//12 isolates, Portugal, September 2022 to May 2023.</fc> Eurosurveillance 28(36). [[https://www.ncbi.nlm.nih.gov/pubmed/37676143/|(PMID: 37676143)]] | Gouveia C, Bajanca-Lavado MP, Mamede R, Araújo Carvalho A, Rodrigues F, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M.]], [[people:afriaes|Friães A]], Portuguese Group for the Study of Streptococcal Infections, Portuguese Study Group of Pediatric Invasive Streptococcal Disease. 2023. <fc #0000FF>Sustained increase of paediatric invasive //Streptococcus pyogenes// infections dominated by M1<sub>UK</sub> and diverse //emm//12 isolates, Portugal, September 2022 to May 2023.</fc> Eurosurveillance 28(36). [[https://www.ncbi.nlm.nih.gov/pubmed/37676143/|(PMID: 37676143)]] | ||
- | Xie O, Morris JM, Hayes AJ, Towers RJ, Jespersen MG, Lees JA, Zakour NLB, Berking O, Baines SL, Carter GP, Tonkin-Hill G, Schrieber L, McIntyre L, Lacey JA, James TB, Sriprakash KS, Beatson SA, Hasegawa T, Giffard P, Steer AC, Batzloff MR, Beall BW, [[people:mdpinho|Pinho MD]], [[people:ramirez|Ramirez M.]], Bessen DE, Dougan G, Bentley SD, Walker MJ, Currie BJ, Tong SYC, McMillan DJ, Davies MR. 2023. <fc #0000FF>Inter-species gene flow drives ongoing evolution of //Streptococcus pyogenes// and //Streptococcus dysgalactiae// subsp. //equisimilis//</fc>. bioRxiv [[https://doi.org/10.1101/2023.08.10.552873|(doi: 10.1101/2023.08.10.552873)]]. | ||
Pinto Junior VL, Valadas E, Hanscheid T. 2023. <fc #0000FF>Combating vaccine hesitancy requires knowledge of misfortunes and controversies</fc>. Acta Med Port 36:537–540. [[https://pubmed.ncbi.nlm.nih.gov/37579748/|(PMID: 37579748)]] | Pinto Junior VL, Valadas E, Hanscheid T. 2023. <fc #0000FF>Combating vaccine hesitancy requires knowledge of misfortunes and controversies</fc>. Acta Med Port 36:537–540. [[https://pubmed.ncbi.nlm.nih.gov/37579748/|(PMID: 37579748)]] |